NT5E and familial pancreatic carcinoma: Treatment with a selective CD73 inhibitor also significantly inhibited tumor growth and enhanced gemcitabine activity in pancreatic cancer (JACOBERGER-FOISSAC C, COUSINEAU et al. 2023).